Dietary n-3 polyunsaturated fatty acid intake and all-cause and cardiovascular mortality in adults on hemodialysis: The DIET-HD multinational cohort study.

[1]  K. Polkinghorne,et al.  Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial , 2017, JAMA internal medicine.

[2]  E. Feskens,et al.  A national FFQ for the Netherlands (the FFQ-NL 1.0): validation of a comprehensive FFQ for adults. , 2016, The British journal of nutrition.

[3]  M. Jose,et al.  Associations of fish oil and vitamin B and E supplementation with cardiovascular outcomes and mortality in people receiving haemodialysis: a review , 2015, BMC Nephrology.

[4]  David W. Johnson,et al.  Research Priorities in CKD: Report of a National Workshop Conducted in Australia. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  L. Byham-Gray,et al.  A Review of Dietary Intake Studies in Maintenance Dialysis Patients. , 2015, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[6]  M. Tonelli,et al.  Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis , 2015, The Lancet.

[7]  M. Tonelli,et al.  Cause of Death in Patients with Reduced Kidney Function. , 2015, Journal of the American Society of Nephrology : JASN.

[8]  David W. Johnson,et al.  Nutrition and dietary intake and their association with mortality and hospitalisation in adults with chronic kidney disease treated with haemodialysis: protocol for DIET-HD, a prospective multinational cohort study , 2015, BMJ Open.

[9]  K. Hamazaki,et al.  Inverse association between docosahexaenoic acid and mortality in patients on hemodialysis during over 10 years , 2014, Hemodialysis international. International Symposium on Home Hemodialysis.

[10]  T. Wadden,et al.  Reprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. , 2014, Journal of the American Pharmacists Association : JAPhA.

[11]  L. Byham-Gray,et al.  Comparison of dietary intake among women on maintenance dialysis to a Women's Health Initiative cohort: results from the NKF-CRN Second National Research Question Collaborative Study. , 2014, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[12]  J. Carrero,et al.  Dietary fat modification in patients with chronic kidney disease: n-3 fatty acids and beyond. , 2013, Journal of nephrology.

[13]  S. Fukumoto,et al.  Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  M. Bossola,et al.  Dietary intake of macronutrients and fiber in Mediterranean patients on chronic hemodialysis. , 2013, Journal of nephrology.

[15]  G. Corrao,et al.  Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected]. , 2013, Atherosclerosis Supplements.

[16]  Zhangsheng Yu,et al.  Inverse relationship between long chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis , 2013, Kidney international.

[17]  J. Carrero,et al.  Essential polyunsaturated fatty acids, inflammation and mortality in dialysis patients. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  W. McClellan,et al.  Influence of race, ethnicity and socioeconomic status on kidney disease , 2012, Nature Reviews Nephrology.

[19]  L. Serra-Majem,et al.  Dietary methods and biomarkers of omega 3 fatty acids: a systematic review , 2012, British Journal of Nutrition.

[20]  M. Tonelli,et al.  Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. , 2012, JAMA.

[21]  A. Webster,et al.  Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease , 2012, Annals of Internal Medicine.

[22]  K. Kalantar-Zadeh,et al.  Dietary intake in hemodialysis patients does not reflect a heart healthy diet. , 2011, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[23]  K. Kalantar-Zadeh,et al.  Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  M. Landray,et al.  The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial , 2011, The Lancet.

[25]  T. Haahtela,et al.  Use of a common food frequency questionnaire (FFQ) to assess dietary patterns and their relation to allergy and asthma in Europe: pilot study of the GA2LEN FFQ , 2011, European Journal of Clinical Nutrition.

[26]  P. Marik,et al.  Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review , 2009, Clinical cardiology.

[27]  Gert Mayer,et al.  Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. , 2009, The New England journal of medicine.

[28]  Anita M Saran,et al.  Cardiovascular disease in chronic kidney disease , 2008, Therapeutic advances in cardiovascular disease.

[29]  C. Saha,et al.  Feasibility study of erythrocyte long-chain omega-3 polyunsaturated fatty acid content and mortality risk in hemodialysis patients. , 2008, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[30]  Gissi-Hf Investigators.  Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[31]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, Journal of clinical epidemiology.

[32]  Peter Stenvinkel,et al.  Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[33]  Y. Matsuzawa,et al.  Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis , 2007, The Lancet.

[34]  Dariush Mozaffarian,et al.  Fish intake, contaminants, and human health: evaluating the risks and the benefits. , 2006, JAMA.

[35]  Judith Wylie-Rosett,et al.  Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee , 2006, Circulation.

[36]  E. Schmidt,et al.  N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[37]  S. Perkins,et al.  Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  W. März,et al.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.

[39]  K. D. Workgroup.  K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  Trevor A. Mori,et al.  Effect of fish and fish oil-derived omega-3 fatty acids on lipid oxidation , 2004, Redox report : communications in free radical research.

[41]  L. Beilin,et al.  Omega-3 fatty acids and inflammation , 2004, Current atherosclerosis reports.

[42]  F. Port,et al.  Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. , 2002, Kidney international.

[43]  Craig S. Wong,et al.  Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  C. Schindler,et al.  N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. , 2002, The American journal of medicine.

[45]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[46]  Roberto Marchioli,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .

[47]  H. Knapp,et al.  Dietary fatty acids in human thrombosis and hemostasis. , 1997, The American journal of clinical nutrition.

[48]  J. Bergström.  Anorexia in dialysis patients. , 1996, Seminars in nephrology.

[49]  L. Tavazzi,et al.  ect of n-3 polyunsaturated fatty acids in patients with chronic heart failure ( the GISSI-HF trial ) : a randomised , double-blind , placebo-controlled trial , 1980 .

[50]  M. Gellens,et al.  Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial. , 2002, Journal of the American Society of Nephrology : JASN.

[51]  A. Leaf.  The electrophysiologic basis for the antiarrhythmic and anticonvulsant effects of n−3 polyunsaturated fatty acids: Heart and brain , 2001, Lipids.